LITTLE FALLS, N.J., Jan. 20, 2011 /PRNewswire/ -- Regenicin, Inc. (OTC Bulletin Board: RGIN) a biotechnology company specializing in the development of and commercialization of regenerative cell therapies to restore the health of damaged tissues and organs, announced today that the company will be represented by former U.S. Congressman Curt Weldon at The Future of Financial Markets (FOFM 2011) Leadership Summit, January 20-22, 2011, at the Renaissance Mumbai Convention Centre Hotel, Powai, Mumbai. This Annual Conference is invitation only and attended by 400 of India's premier financial and investment leaders.
"This conference provides an opportunity for Curt to speak passionately about Regenicin and the company's role in bringing new breakthroughs in regenerative medicine to market," says Regenicin's CEO, Randall McCoy, who recently contracted the former Congressman as a business development consultant for the company. "It also provides the perfect forum for Curt to explore business development and investment opportunities for Regenicin in the global market."
Weldon, who served as a Republican member of the United States House of Representatives from 1987-2007, representing the 7th district of Pennsylvania, will present Regenicin's unique business model and core strategy for 2011. Key components of Regenicin's strategy include identifying promising new therapeutic candidates that address unmet needs in growing markets; developing the most strategic, economical and expeditious pathways for achieving regulatory approval by the FDA; and creating a commercialization pipeline for bringing new candidates to market once FDA approved.
Currently Regenicin is playing a critical role in developing an exciting breakthrough technology that uses the patient's own skin cells to generate living, tissue-engineered skin for the treatment of catastrophic burns.
|SOURCE Regenicin, Inc.|
Copyright©2010 PR Newswire.
All rights reserved